The role of COPD and inhaled corticosteroids in major adverse cardiovascular events in cardiovascular-kidney-metabolic populations
Anne E Ioannides(Imperial College London), Jennifer K. Quint(London Biofoundry), Emily L. Graul(Emory University), Upasana Tayal(Royal Brompton & Harefield NHS Foundation Trust), Constantinos Kallis(Imperial College London), Hana Mullerova(AstraZeneca (France))
Cited by 1
Related Papers
Genetic Variants Associated With Cancer Therapy–Induced Cardiomyopathy
|Circulation|2019|344
Genetic Etiology for Alcohol-Induced Cardiac Toxicity
|Journal of the American College of Cardiology|2018|300
Temporal Risk of Nonfatal Cardiovascular Events After Chronic Obstructive Pulmonary Disease Exacerbation: A Population-based Study
|American Journal of Respiratory and Critical Care Medicine|2023|79
Determining prescriptions in electronic healthcare record data: methods for development of standardized, reproducible drug codelists
|JAMIA Open|2023|14
Supporting the role and enabling the potential of community health workers in Bangladesh’s rural maternal and newborn health programs: a qualitative study
|Journal of Global Health Reports|2020|9